Status:

UNKNOWN

Clinical Application of Non-invasive Assessment for Staging Liver Steatosis and Liver Fibrosis

Lead Sponsor:

Beijing Friendship Hospital

Conditions:

Nonalcoholic Fatty Liver Disease

Liver Steatosis

Eligibility:

All Genders

18-65 years

Brief Summary

Nowadays, the morbidity of Nonalcoholic fatty liver disease (NAFLD) show ascending trend year by year, which has become an important public health problem in China. As NAFLD can progress to Non-alcoho...

Eligibility Criteria

Inclusion

  • Age:18≤,≥65
  • Gender:male or female
  • NAFLD patient,agree with the paracentesis of liver tissue
  • Regular follow-up
  • Signing the Informed Consent Form

Exclusion

  • Hepatic decompensation:Including cirrhotic complications,such as ascites,hepatic encephalopathy,digestive tract bleeding,hepatorenal syndrome,spontaneous bacterial peritonitis,and HCC.
  • Complications of HBV,HCV,HIV.Complications of alcoholic liver disease,autoimmune liver disease,hereditary metabolic liver disease, drug-induced liver disease and other chronic liver disease.
  • AFP\>100ng/ml and imaging indicates malignant occupying.Or AFP still\>100ng/ml within 3 months.
  • Creatinine was 1.5 times higher than the upper limit of the normal value.
  • Combined with other malignant tumors(except those cured).
  • Serious diseases of heart, lung, kidney, brain, blood and other important organs with dysfunction.
  • severe neurological and psychiatric diseases (such as epilepsy, depression, mania, schizophrenia, etc.)
  • Pregnant women and breast-feeding women.
  • The researchers consider that it is not suitable for the patients to participate in this study.

Key Trial Info

Start Date :

December 1 2015

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 31 2018

Estimated Enrollment :

400 Patients enrolled

Trial Details

Trial ID

NCT03386890

Start Date

December 1 2015

End Date

December 31 2018

Last Update

December 29 2017

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Beijing Friendship Hospital

Beijing, Beijing Municipality, China, 100000

Clinical Application of Non-invasive Assessment for Staging Liver Steatosis and Liver Fibrosis | DecenTrialz